CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox in Hospitalized Patients.

Trial Profile

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox in Hospitalized Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2014

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Acronyms CAPRIVI
  • Sponsors Bayer
  • Most Recent Events

    • 14 Nov 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top